XML 50 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Events after the end of the reporting period (Details) - Global exclusive license agreement with Novartis [member]
€ in Millions
Jul. 19, 2018
EUR (€)
Disclosure of non-adjusting events after reporting period [line items]  
Future upfront payments € 95
Potential future milestone payments € 850